This behavior is even more relevant if one considers that IL-10 is associated with the dampening of intestinal inflammation, IBD and ulcerative colitis risk reduction, as this interferon limits the secretion of pro-inflammatory cytokines, deactivates macrophages and inhibits the secretion of Th1-related cytokines [61,62,63]. The gene discussed is NELFCD; the disease is inflammatory bowel disease.